We observed that PVR-TIGIT interaction was enriched between tumor cells and Tregs in the papillary and solid patterns, implying that blockade of the PVR-TIGIT axis is a potentially effective treatment for LUAD patients with papillary and solid patterns. The gene discussed is PVR; the disease is neoplasm.